Danolić, D., Kasum, M., Puljiz, M., Alvir, I., Tomica, D., Mamić, I. ... Bolanča, I. (2015). The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome. Acta clinica Croatica, 54. (2), 186-192. Retrieved from https://urn.nsk.hr/urn:nbn:hr:220:373984
Danolić, Damir, et al. "The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome." Acta clinica Croatica, vol. 54, no. 2, 2015, pp. 186-192. https://urn.nsk.hr/urn:nbn:hr:220:373984
Danolić, Damir, Miro Kasum, Mario Puljiz, Ilija Alvir, Darko Tomica, Ivica Mamić, Ermin Čehić and Ivan Bolanča. "The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome." Acta clinica Croatica 54, no. 2 (2015): 186-192. https://urn.nsk.hr/urn:nbn:hr:220:373984
Danolić, D., et al. (2015) 'The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome', Acta clinica Croatica, 54(2), pp. 186-192. Available at: https://urn.nsk.hr/urn:nbn:hr:220:373984 (Accessed 13 December 2024)
Danolić D, Kasum M, Puljiz M, Alvir I, Tomica D, Mamić I, and sur.. The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome. Acta clinica Croatica [Internet]. 2015 [cited 2024 December 13];54(2):186-192. Available at: https://urn.nsk.hr/urn:nbn:hr:220:373984
D. Danolić, et al., "The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome", Acta clinica Croatica, vol. 54, no. 2, pp. 186-192, 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:220:373984. [Accessed: 13 December 2024]